Published in Cancer Weekly, February 14th, 2006
"This study evaluates the efficacy and toxicity of single agent irinotecan following hepatectomy for metachronous colorectal metastases, and examines the predictive value of p27 and p53 expression and of microsatellite instability (MSI) status," scientists writing in the American Journal of Clinical Oncology - Cancer Clinical Trials reported.
"Twenty-nine patients, previously treated with 5-fluorouracil, with operable hepatic colorectal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.